Russian Cardiological Research and Industrial Complex for Russian Medical Technologies

Moscow, Russia

Russian Cardiological Research and Industrial Complex for Russian Medical Technologies

Moscow, Russia
SEARCH FILTERS
Time filter
Source Type

Gurskii Y.G.,Russian Cardiological Research and Industrial Complex for Russian Medical Technologies | Minashkin M.M.,Russian Cardiological Research and Industrial Complex for Russian Medical Technologies | Feoktistova E.S.,Russian Cardiological Research and Industrial Complex for Russian Medical Technologies | Skamrov A.V.,Russian Cardiological Research and Industrial Complex for Russian Medical Technologies | And 2 more authors.
Applied Biochemistry and Microbiology | Year: 2010

A recombinant plasmid carrying a modified gene of human plasminogen (mini-plasminogen), lacking four kringle domains and an amino terminal fragment, and containing an additional oligopeptide of six N-terminal histidine residues has been constructed. The plasmid was used for transformation of E. coli JM 109 cells to obtain a strain producing a recombinant modified human plasminogen. The target protein is superexpressed in a form of inclusion bodies and is composed of more than 50% insoluble protein. The renaturated and chromatographically purified protein exhibits amidolytic activity specific for plasminogen proenzyme in a fibrinolytic system. © 2010 Pleiades Publishing, Ltd.

Loading Russian Cardiological Research and Industrial Complex for Russian Medical Technologies collaborators
Loading Russian Cardiological Research and Industrial Complex for Russian Medical Technologies collaborators